Biotech Stocks Could Use A Win — Will The First Quarter Offer That?

Biotech Stocks Could Use A Win — Will The First Quarter Offer That?

Gilead Sciences, Biogen and Vertex Pharmaceuticals could top expectations in an otherwise soft quarter for biotech stocks, an analyst said Thursday. He sees key products beating forecasts.